Hot M&A Dealsheets

On October 29, 2025, Thermo Fisher Scientific Inc. announced a definitive agreement to acquire Clario Holdings, Inc. — a clinical-trial endpoint data solutions provider — for approximately US $8.875 billion in cash at closing, plus an additional US $125 million in January 2027 and up to US $400 million of performance-based earn-out payments tied to Clario’s 2026-27 results. The deal, expected to close by mid-2026 subject to regulatory approvals, will integrate Clario into Thermo Fisher’s Laboratory Products and Biopharma Services segment, immediately enhance adjusted earnings per share by about US $0.45 in year one, and deliver meaningful margin and growth synergies as Thermo scales its digital-data capabilities for pharma and biotech customers

The acquisition increases the scope of Hewlett Packard’s networking business and will create meaningful opportunities to provide even more comprehensive solutions to Juniper’s installed base of enterprise customers, communication service providers and tier‐one cloud customers, as well as launches Hewlett Packard into adjacent large segments, including data center networking, firewalls, and routers.